By Dhirendra Tripathi
Investing.com -- Stocks rose on the first trading day of 2022, fueled by Apple’s climb above $3 trillion in market value, the first-ever to reach that milestone.
The markets were trying to extend a rally into the new year. Elsewhere, Tesla shares rose 9% after the electric car maker revealed fourth quarter deliveries that were far and away above Wall Street expectations, despite a chip shortage.
Even airline stocks were on the rise despite the cancellation of thousands of flights over the New Year’s weekend, when travelers were trying to return home from holiday trips. The cancellations and delays happened because of winter weather snarling airports across the Midwest and East Coast and staffing shortages because of Covid cases.
Wall Street's main indexes ended 2021 with monthly, quarterly and annual gains, recording their biggest three-year advance since 1999, Reuters reported on Monday.
The S&P 500 rose 27% last year, with 70 record-high closes.
It’s a light week for data and earnings, though Tuesday will see the latest job openings report.
Here are three things that could affect markets tomorrow:
1. Tesla deliveries
While the news of Tesla Inc (NASDAQ:TSLA)’s successful fourth quarter in terms of vehicles delivered came out over the weekend, the stock reacted positively on Monday and was likely to continue to react on Tuesday. Stocks and ADRs of Chinese rivals gained as well as their latest sales numbers reflected strong demand for electric vehicles.
Tesla delivered 308,600 vehicles in the fourth quarter, much higher than analysts' forecasts of 263,026 vehicles, according to Reuters.
2. Apple’s meteoric rise
Apple Inc (NASDAQ:AAPL) shares topped the $3 trillion threshold in market value on Monday, just a little more than one year after topping the $2 trillion mark. The iPhone maker has shown resilience during the reopening trade despite chip shortages. Analysts believe it sold a record number of iPhones during the last quarter and more positive news is expected this year from a virtual reality headset.
3. Vaccine news
Pfizer Inc (NYSE:PFE) continued its momentum after the U.K.’s approval of the company’s Covid-19 pill, which boosts chances of the oral drug finding wider acceptance amid omicron surge.
The Medicines and Healthcare products Regulatory Agency’s nod came Friday. The pill already has the U.S. Food and Drug Administration’s approval.
Meanwhile Moderna Inc (NASDAQ:MRNA) stock got dinged after the FDA expanded the use of the Covid-19 booster shots made by rivals Pfizer and BioNTech SE (NASDAQ:BNTX) for younger teenagers.
-- Investing.com staff contributed to this report